SCHEMBL30810239

SCHEMBL30810239

COC(=O)c1cc(Cl)cc(CBr)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
HPGD P15428 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ABL1 P00519 1/20 0.41
SERPINH1 P50454 1/20 0.40
GALK1 P51570 1/20 0.40
ACLY P53396 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 2/20 0.40
GAA P10253 2/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612141 1.00 KDM4E (0.43) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL30810287 0.87 KDM4E (0.45) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL30810313 0.86 KDM4E (0.48) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL19612138 0.86 KDM4E (0.48) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL30810366 0.86 KDM4E (0.52) KDM4EHPGDALDH1A1ACLYGAA
SCHEMBL30810413 0.83 KMT2A (0.43) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL19612171 0.82 ALDH1A1 (0.41) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL30810291 0.82 ABL1 (0.42) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL19612155 0.82 ABL1 (0.42) KDM4EHPGDALDH1A1NPSR1ABL1
SCHEMBL30810216 0.81 KDM4E (0.40) KDM4EHPGDALDH1A1NPSR1GALK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed